The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

Stephen T. Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G. Trinidad, Jacqueline H.L. Fok, Tom Hunt, Kurt G. Pike, Joanne Wilson, Aaron Smith, Nicola Colclough, Venkatesh Pilla Reddy, Andrew Sykes, Annika Janefeldt, Peter Johnström, Katarina VarnäsAkihiro Takano, Stephanie Ling, Jonathan Orme, Jonathan Stott, Caroline Roberts, Ian Barrett, Gemma Jones, Martine Roudier, Andrew Pierce, Jasmine Allen, Jenna Kahn, Amrita Sule, Jeremy Karlin, Anna Cronin, Melissa Chapman, Kristoffer Valerie, Ruth Illingworth, Martin Pass

Research output: Contribution to journal › Article › peer-review

186 Scopus citations

Fingerprint

Dive into the research topics of 'The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models'. Together they form a unique fingerprint.

Medicine & Life Sciences